Redcare Pharmacy NV reported Q1 2026 group revenue of €848 million, up 18.3% YoY from €717 million.
German Rx revenue surged 55% to €168 million, driving DACH segment revenue to €692 million, up 18.9% YoY.
Active customers rose 8% to 14.2 million, and e‑Rx net promoter score increased to 76 from 73.
Company confirmed its 2026 guidance despite lower prior‑quarter marketing spend affecting Q4 growth.